0
Study | ONLINE FIRST

Prognostic Factors of Paraneoplastic Pemphigus

Sandy Leger, MD; Damien Picard, MD, PhD; Saskia Ingen-Housz-Oro, MD; Jean-Philippe Arnault, MD; François Aubin, MD, PhD; Francis Carsuzaa, MD; Gilles Chaumentin, MD; Jacqueline Chevrant-Breton, MD; Olivier Chosidow, MD, PhD; Béatrice Crickx, MD, PhD; Michel D’incan, MD, PhD; Michel Dandurand, MD; Stéphane Debarbieux, MD; Emmanuel Delaporte, MD, PhD; Olivier Dereure, MD, PhD; Marie-Sylvie Doutre, MD, PhD; Gérard Guillet, MD; Denis Jullien, MD, PhD; Ingrid Kupfer, MD; Jean-Philippe Lacour, MD; Fabienne Leonard, MD; Catherine Lok, MD, PhD; Laurent Machet, MD, PhD; Ludovic Martin, MD, PhD; Carle Paul, MD, PhD; Jean-Michel Pignon, MD; Caroline Robert, MD, PhD; Luc Thomas, MD, PhD; Pierre-Jean Weiller, MD, PhD; Vincent Ferranti, MD; Danièle Gilbert, PhD; Philippe Courville, MD; Estelle Houivet, PhD; Jacques Benichou, MD, PhD; Pascal Joly, MD, PhD
Arch Dermatol. 2012;148(10):1165-1172. doi:10.1001/archdermatol.2012.1830.
Text Size: A A A
Published online

Objective  To identify the prognostic factors of overall survival in a series of patients with paraneoplastic pemphigus (PNP).

Design  Multicenter retrospective cohort study.

Setting  Twenty-seven dermatology departments in France.

Patients  A total of 53 patients (31 men and 22 women; median age, 59 years; age range, 30-88 years) were diagnosed as having PNP between 1992 and 2010.

Main Outcome Measures  Overall Kaplan-Meier survival rates were estimated, and features associated with survival were assessed using univariate (log-rank test) and multivariate (Cox regression) analyses.

Results  The study included 53 patients with PNP. Thirty-six patients (68%) died during the study. The 1-, 3-, and 5-year overall survival rates were 49%, 41%, and 38%, respectively. The main causes of death were infections (n = 21) and evolution of neoplasia (n = 6). In univariate analysis, the main detrimental prognostic factors identified were erythema multiforme–like skin lesions (P = .05) and histologic keratinocyte necrosis (P = .03). None of the 5 patients with Castleman disease died during the study. After adjustment for age and sex in multivariate analysis, erythema multiforme–like skin lesions remained predictive of fatal outcome, with a 2-fold increase in death rate (hazard ratio [HR], 2.3; 95% CI, 1.05-5.03; P = .04). The prognosis of patients with PNP was even poorer when erythema multiforme–like skin lesions were associated with severe skin or mucosal involvement at presentation (HR of death, 3.0; 95% CI, 1.01-8.92; P = .049).

Conclusion  Patients with PNP with erythema multiforme–like skin lesions and histologic keratinocyte necrosis, especially when associated with extensive lesions at presentation, are likely to have a more severe and rapid fatal outcome and should be managed very carefully.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure. Overall survival distribution of the 53 patients with paraneoplastic pemphigus. A, Whole population. B, Patients with non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), carcinoma, or other types of neoplasm (Other). C, Patients with or without erythema multiforme (EM)-like lesions. D, Patients with or without keratinocyte necrosis.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs